American journal of cardiovascular disease最新文献

筛选
英文 中文
Risk factors for cardiovascular diseases during medical academic training. 医学学术培训期间心血管疾病的危险因素。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Marcos Thiago Faé, Marcelo Vier Gambetta, Nicolas Ramos, Samantha Cristiane Lopes, Caroline Oliveira Fischer Bacca
{"title":"Risk factors for cardiovascular diseases during medical academic training.","authors":"Marcos Thiago Faé,&nbsp;Marcelo Vier Gambetta,&nbsp;Nicolas Ramos,&nbsp;Samantha Cristiane Lopes,&nbsp;Caroline Oliveira Fischer Bacca","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular diseases (CVDs) are the main cause of morbidity and mortality in the world. Previous studies disagree about the prevalence of cardiovascular risk factors (CVRFs) among medical students.</p><p><strong>Objectives: </strong>Determine the CVRFs prevalence in medical students. Compare the FRCVs percentage from initial and advanced course stages. Evaluate whether the CVRFs percentage was similar to that from population in the same age group, as previously described in another studies.</p><p><strong>Method: </strong>This is a cross-sectional observational study that evaluated the CVRFs prevalence in medical students using a semi-structured questionnaire, in addition to physical examination and laboratory tests. For statistical analysis, statistical package for the social science software (SPSS, version 22.0) was used.</p><p><strong>Results: </strong>115 students were evaluated: 74.8%, female; mean age, 22.4±3.1 years. In the general sample was found altered dosages of total cholesterol (27.0%), high density lipoprotein cholesterol (HDL, 5.2%), triglycerides (12.2%), low density lipoprotein cholesterol (LDL, 8.7%), fasting glucose (4.3%), overweight (17.4%), obesity (5.2%), inadequate physical activity (45.2%), family history of cardiovascular disease (44.3%), stress (68.7%), anxiety (83.5%), insomnia (28.7%), sleep deprivation (60.0%), alcohol use (91.3%) and low cardiovascular risk (100.0%). The average score from PSS-14 questionnaire showed greater stress in the basic (27.0±6.7) and clinical cycle (28.3±7.1) and less stress in the internship (22.3±6.4). There was a statistical difference between the clinical cycle and internship (P < 0.05). During internship, there was a lower association between stress and graduation (33.3%), especially when compared to the clinical cycle (75.4%) (P < 0.01; ra=2.9).</p><p><strong>Conclusion: </strong>CVRFs exposure and the risk of negative cardiovascular outcomes are lower in medical students when compared to young adult population. Suggestive of medical training contributes to self-care, health promotion, stress reduction and disease prevention, reducing the cardiovascular diseases prevalence, especially in the internship.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 4","pages":"252-263"},"PeriodicalIF":1.3,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509451/pdf/ajcd0013-0252.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41094861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Very low risk of ST-elevation and non-ST-elevation myocardial infarction in patients with chest trauma. 胸部创伤患者发生ST段抬高和非ST段抬高心肌梗死的风险非常低。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Lucy Hickcox, Mehrtash Hashemzadeh, Mohammad Reza Movahed
{"title":"Very low risk of ST-elevation and non-ST-elevation myocardial infarction in patients with chest trauma.","authors":"Lucy Hickcox,&nbsp;Mehrtash Hashemzadeh,&nbsp;Mohammad Reza Movahed","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>The goal of this study was to evaluate any association between blunt chest trauma and occurrence of ST-elevation myocardial infarction and non-ST-elevation myocardial infarction.</p><p><strong>Methods: </strong>Data from the National Inpatient Sample (NIS) database from 2010-2014, of patients over the age of 40, hospitalized for blunt chest trauma (ICD 959.11), with STEMI or NSTEMI, was used in this study. We performed a chi-squared test to analyze this association. We also performed a multivariant analysis adjusting for race, gender, and age.</p><p><strong>Results: </strong>We found that there is not an increased risk of STEMI/NSTEMI following blunt chest trauma, P > 0.05. We also found no correlation between STEMI or NSTEMI and chest trauma after adjusting for race, gender, and age. For STEMI after adjustments in 2010 (P=0.52), 2011 (P=0.19), 2012 (P=0.60), 2013 (P=0.88), and 2014 (P=0.14). For NSTEMI adjustments in 2010 (P=0.03), 2011 (P=0.06), 2012 (P=0.01), 2013 (P=0.21), and 2014 (P=0.03).</p><p><strong>Conclusion: </strong>Both ST-elevation myocardial infarction and non-ST-elevation myocardial infarction were not significantly associated with blunt chest trauma.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 4","pages":"247-251"},"PeriodicalIF":1.3,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509452/pdf/ajcd0013-0247.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41102632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcatheter aortic valve replacement among heart transplant recipients with donor aortic valve diseases: a systematic review of the literature. 患有供体主动脉瓣疾病的心脏移植受者经导管主动脉瓣置换术:文献系统综述。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Saeed Shoar, Ashok Chaudhary, Varinder Bansro, Mohammad Sadegh Asadi
{"title":"Transcatheter aortic valve replacement among heart transplant recipients with donor aortic valve diseases: a systematic review of the literature.","authors":"Saeed Shoar,&nbsp;Ashok Chaudhary,&nbsp;Varinder Bansro,&nbsp;Mohammad Sadegh Asadi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Despite high surgical risk among heart transplant (HTx) recipients, who develop aortic valve diseases (AVD), transcutaneous aortic valve replacement (TAVR) has been scarcely reported as a viable option in this patient population.</p><p><strong>Methods: </strong>A systematic review was conducted to identify studies reporting the outcomes of HTx recipients who developed AVD of the donor heart and underwent TAVR. Studies were eligible if they provided individual-level data for HTx recipients, who underwent TAVR on the donor heart. Review articles, editorials or commentaries, studies lacking original data, or those reporting surgical valve replacement for AVD in HTx recipients were excluded.</p><p><strong>Results: </strong>A total of 15 case reports, encompassing 15 patients, describing characteristics and outcomes of HTx recipients undergoing TAVR were included. These included 13 males and 2 females with an average age of 63.6±15 years. The indications for HTx were non-ischemic dilated cardiomyopathy, ischemic cardiomyopathy and ischemic dilated cardiomyopathy in 42.9%, 35.7%, and 21.4% of the patients, respectively. The main indication for aortic valve replacement (AVR) among HTx recipients was aortic stenosis (73.3%). The transcutaneous approach was preferred over surgical AVR due to high surgical risk in > 50% of the patients. Both pre-TAVR transvalvular pressure gradient and the peak aortic pressure gradient decreased after the TAVR. Paravalvular leak was minimal/none to mild in all the patients post-TAVR. Most patients had an uneventful post-TAVR recovery with no recurrence of the symptoms or echocardiographic finings at a median follow-up of 6 months.</p><p><strong>Conclusions: </strong>TAVR seems to be a viable option for HTx recipients who develop donor aortic valve diseases. However, there is a paucity of knowledge on the long-term survivability of the replaced aortic valves and the clinical and echocardiographic outcomes of HTx recipients undergoing TAVR.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 4","pages":"235-246"},"PeriodicalIF":1.3,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509455/pdf/ajcd0013-0235.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41111348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Female-specific risk factors of parity and menopause age and risk of carotid plaque: the multi-ethnic study of atherosclerosis. 产程、绝经年龄和颈动脉斑块风险的女性特异性危险因素:动脉粥样硬化的多民族研究。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Carla P Rodriguez, Oluseye Ogunmoroti, Anum S Minhas, Dhananjay Vaidya, Brigitte Kazzi, Olatokunbo Osibogun, Seamus Whelton, Lara C Kovell, Colleen M Harrington, Michael C Honigberg, Ritu Thamman, James H Stein, Michael D Shapiro, Erin D Michos
{"title":"Female-specific risk factors of parity and menopause age and risk of carotid plaque: the multi-ethnic study of atherosclerosis.","authors":"Carla P Rodriguez, Oluseye Ogunmoroti, Anum S Minhas, Dhananjay Vaidya, Brigitte Kazzi, Olatokunbo Osibogun, Seamus Whelton, Lara C Kovell, Colleen M Harrington, Michael C Honigberg, Ritu Thamman, James H Stein, Michael D Shapiro, Erin D Michos","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Female-specific factors of grand multiparity (≥5 births) and early menopause age are associated with an increased risk of cardiovascular disease (CVD). However, mechanisms are incompletely understood. Carotid plaque is a marker of subclinical atherosclerosis and associated with increased CVD risk. We evaluated the association of female-specific factors with plaque burden.</p><p><strong>Methods: </strong>We included 2,313 postmenopausal women in the Multi-Ethnic Study of Atherosclerosis, free of clinical CVD, whose parity and menopause age were ascertained by questionnaires and carotid plaque measured by ultrasound at baseline and 10 years later. Parity was categorized as nulliparity (reference), 1-2, 3-4 and ≥5 live births. Menopause age was categorized as <45, 45-49, 50-54 (reference) and ≥55 years. Multivariable regression was performed to evaluate the association of parity and menopause age with carotid plaque presence (yes/no) and extent [carotid plaque score (CPS)].</p><p><strong>Results: </strong>The mean age was 64±9 years; 52.3% had prevalent carotid plaque at baseline. Compared to nulliparity, grand multiparity was significantly associated with prevalent carotid plaque after adjustment for CVD risk factors (prevalence ratio 1.17 (95% CI 1.03-1.35)) and progression of CPS over 10 years [percent difference 13% (95% CI 3-23)]. There was not any significant association of menopause age with carotid plaque presence or progression in fully-adjusted models.</p><p><strong>Conclusion: </strong>In a multiethnic cohort, grand multiparity was independently associated with carotid plaque presence and progression. Early menopause, a known risk factor for CVD, was not captured by carotid plaque in this study. These findings may have implications for refining CVD risk assessment in women.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 4","pages":"222-234"},"PeriodicalIF":1.3,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509453/pdf/ajcd0013-0222.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41097448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodality imaging in diagnosis and management of patent ductus arteriosus in an adult: a case report. 成人动脉导管未闭的多模态成像诊断和治疗:一例报告。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Leila Najmafshar, Mansoreh Abdolhosseini, Asadolah Tanasan, Masoumeh Abdolhosseini, Seyed Kianoosh Hosseini
{"title":"Multimodality imaging in diagnosis and management of patent ductus arteriosus in an adult: a case report.","authors":"Leila Najmafshar,&nbsp;Mansoreh Abdolhosseini,&nbsp;Asadolah Tanasan,&nbsp;Masoumeh Abdolhosseini,&nbsp;Seyed Kianoosh Hosseini","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Patent ductus arteriosus (PDA) is a congenital heart disorder in which a vascular structure between the pulmonary artery and the aorta remains open. PDA normally closes shortly after birth. The treatment in adults is surgical or transcatheter closure. A 47-year-old woman presented to our hospital with a diagnosis of PDA and was treated with transcatheter closure. Although the recovery period of adult patients is long, this patient recovered completely after one day.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 4","pages":"272-277"},"PeriodicalIF":1.3,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509450/pdf/ajcd0013-0272.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41099682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CYP2D6 and ADRB1 genetic polymorphisms and the selection of antihypertensive beta-receptor blockers for hypertensive patients. CYP2D6和ADRB1基因多态性与高血压患者抗高血压β受体阻滞剂的选择。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Keping Chen, Ying Li, Chuankun Yang, Peng Xiao, Guochun Li, Yurong Xu
{"title":"<i>CYP2D6</i> and <i>ADRB1</i> genetic polymorphisms and the selection of antihypertensive beta-receptor blockers for hypertensive patients.","authors":"Keping Chen,&nbsp;Ying Li,&nbsp;Chuankun Yang,&nbsp;Peng Xiao,&nbsp;Guochun Li,&nbsp;Yurong Xu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Genetic factors contribute to the variability in individual response to antihypertensive medications. We sought to investigate the frequencies of allele and genotype for <i>CYP2D6</i> and <i>ADRB1</i> genetic polymorphisms and explore their potential impact in influencing the selection of antihypertensive beta-receptor blockers.</p><p><strong>Methods: </strong>The study population was selected from the Han Chinese patients in Zhongda Hospital, which contained 2419 Han Chinese hypertensive individuals and 151 normotensive controls. Each of the above participants underwent venous blood sampling. Then, the gene chip platform was adopted to evaluate the <i>CYP2D6</i> and <i>ADRB1</i> genetic polymorphisms. The allele as well as genotype frequencies for each gene, along with the combined genotypes, were subjected to analysis.</p><p><strong>Results: </strong>The frequency of *1/*1 wild-type homozygous for <i>CYP2D6</i> was 9.71%, while the frequency of *1/*10 heterozygous or *10/*10 mutant homozygous was 59.16% or 31.13%, respectively, as established by gene chip analysis. Similarly, we observed that the genotype frequencies of GG wild-type homozygous for <i>ADRB1</i> was 10.29%, while that of GC heterozygous, or CC mutant homozygous was 44.98%, or 44.73%, respectively. Notably, combined genotypes *1/*10 + CC (25.88%) and *1/*10 + CG (27.78%) had the highest frequencies. Importantly, no substantial differences in the distributions of <i>CYP2D6</i> and <i>ADRB1</i> polymorphism were noted between hypertensive patients and normotensive controls, or among all different grades of hypertension.</p><p><strong>Conclusion: </strong>These findings provide insights into the <i>CYP2D6</i> and <i>ADRB1</i> polymorphisms in hypertensive patients from Han Chinese, which show significant differences compared to other geographic groups of Han Chinese hypertensive patients. These results offer valuable information for future prospective clinical studies on the antihypertensive effects of beta-receptor blockers in Han Chinese hypertensive patients.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 4","pages":"264-271"},"PeriodicalIF":1.3,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509456/pdf/ajcd0013-0264.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41102631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contemporary management of ventricular arrhythmias in heart failure. 心力衰竭室性心律失常的现代治疗。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Ourania Kariki, Maximos Georgopoulos, Nikitas Katsillis, Anastasios Chatziantoniou, Stavroula Koskina, Andromahi Zygouri, Athanasios Saplaouras, George Bazoukis, Aggeliki Gkouziouta, Konstantinos Vlachos, Stylianos Dragasis, Panagiotis Mililis, Stamatis Adamopoulos, Michael Efremidis, Konstantinos P Letsas
{"title":"Contemporary management of ventricular arrhythmias in heart failure.","authors":"Ourania Kariki, Maximos Georgopoulos, Nikitas Katsillis, Anastasios Chatziantoniou, Stavroula Koskina, Andromahi Zygouri, Athanasios Saplaouras, George Bazoukis, Aggeliki Gkouziouta, Konstantinos Vlachos, Stylianos Dragasis, Panagiotis Mililis, Stamatis Adamopoulos, Michael Efremidis, Konstantinos P Letsas","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Enhanced ventricular arrhythmogenesis is commonly experienced by patients in the end-stage of heart failure spectrum. A high burden of ventricular arrhythmias can affect the ventricular systolic function, lead to unexpected hospitalizations and further deteriorate the prognosis. Management of ventricular arrhythmias in this population is challenging. Implantable cardioverter-defibrillators are protective for the immediate termination of life-threatening arrhythmias but they have no impact in reducing the arrhythmic burden. Combination treatment with invasive (catheter ablation, mechanical hemodynamic support, sympathetic denervation) and noninvasive (antiarrhythmic drugs, medical therapy for heart failure, programming of implantable devices) therapies is commonly required. The aim of this review is to present the available therapeutic options, with main focus on recently published data for catheter ablation and provide a stepwise treatment approach.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 4","pages":"207-221"},"PeriodicalIF":1.3,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509449/pdf/ajcd0013-0207.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41128375","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
First reported case of COVID-19 induced permanent third-degree atrioventricular (AV) block in a young patient. 首次报告新冠肺炎在一名年轻患者中诱发永久性三度房室传导阻滞的病例。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-08-15 eCollection Date: 2023-01-01
Lucy Hickcox, Matthew Rw Smolin, Mohammad Reza Movahed
{"title":"First reported case of COVID-19 induced permanent third-degree atrioventricular (AV) block in a young patient.","authors":"Lucy Hickcox,&nbsp;Matthew Rw Smolin,&nbsp;Mohammad Reza Movahed","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>SARS-CoV2 virus, COVID-19, was first reported in Wuhan, China in 2019. The most common symptoms of COVID-19 are dry cough, fever, and diarrhea that occur within 2-14 days of exposure. Primary infection from COVID-19 develops in the respiratory tract. Cardiovascular disease has become a more prominent manifestation of COVID-19 infection, however very little is known regarding the impact of COVID-19 on the cardiac conduction system. We present a young patient with COVID-19 who developed a permanent third-degree Atrioventricular (AV) heart block. This report is the first documentation of COVID-19 induced permanent third-degree heart block in a young male.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 4","pages":"278-282"},"PeriodicalIF":1.3,"publicationDate":"2023-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509457/pdf/ajcd0013-0278.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41100352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinician's guide to addressing cardiovascular health based on a revised AHA framework. 基于修订后的 AHA 框架的临床医生心血管健康指南。
IF 1.3
American journal of cardiovascular disease Pub Date : 2023-04-15 eCollection Date: 2023-01-01
Neel Koyawala, Lena M Mathews, Francoise A Marvel, Seth S Martin, Roger S Blumenthal, Garima Sharma
{"title":"A clinician's guide to addressing cardiovascular health based on a revised AHA framework.","authors":"Neel Koyawala, Lena M Mathews, Francoise A Marvel, Seth S Martin, Roger S Blumenthal, Garima Sharma","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The American Heart Association recently published updates to its definition of cardiovascular health (CVH) in its Presidential Advisory called Life's Essential 8. In particular, the update from Life's Simple 7 added a new component of sleep duration and refined definitions of prior components, including measurement of diet, nicotine exposure, blood lipids, and blood glucose. Physical activity, BMI, and blood pressure were unchanged. Together, these eight components create a composite CVH score that clinicians, policy-makers, patients, communities, and businesses can utilize to communicate in a consistent way. Life's Essential 8 also emphasizes the critical role of addressing social determinants of health to improve these individual CVH components, which strongly correlate with future cardiovascular outcomes. This framework should be used across the life spectrum including during pregnancy and childhood to allow improvements in and prevention of CVH at critical time-points. Clinicians can use this framework to advocate for digital health technologies and societal policies that help address and more seamlessly measure the 8 components of CVH with the goal of increasing quality and quantity of life.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 2","pages":"52-58"},"PeriodicalIF":1.3,"publicationDate":"2023-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10193249/pdf/ajcd0013-0052.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9507546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of fragmented QRS in acute pulmonary embolism: a cross-sectional-analytic study of the Iranian population. 碎片化QRS在急性肺栓塞中的预后价值:伊朗人群的横断面分析研究。
IF 1.3
Mahsa Asadi Anar, Akram Ansari, Gisou Erabi, Mohammad Rahmanian, Mahdiyeh Movahedi, Fatemeh Chichagi, Niloofar Deravi, Farid Taghavi, Babak Kazemi, Elnaz Javanshir, Erfan Amouei, Samad Ghaffari
{"title":"Prognostic value of fragmented QRS in acute pulmonary embolism: a cross-sectional-analytic study of the Iranian population.","authors":"Mahsa Asadi Anar,&nbsp;Akram Ansari,&nbsp;Gisou Erabi,&nbsp;Mohammad Rahmanian,&nbsp;Mahdiyeh Movahedi,&nbsp;Fatemeh Chichagi,&nbsp;Niloofar Deravi,&nbsp;Farid Taghavi,&nbsp;Babak Kazemi,&nbsp;Elnaz Javanshir,&nbsp;Erfan Amouei,&nbsp;Samad Ghaffari","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Acute Pulmonary embolism (APE) is considered one of the deadliest cardiovascular diseases. Electrocardiographic (ECG) abnormalities in pulmonary embolism (PE) are increasingly reported. A growing number of studies have recommended that ECG plays a crucial role in the prognostic assessment of PE patients. However, there is scarce data on the prognostic importance of fragmented QRS (fQRS) on outcomes in patients with APE. This study aims to investigate the prognostic value of fQRS in APE patients.</p><p><strong>Materials and methods: </strong>This is a cross-sectional-analytic study. This study included 280 patients diagnosed with APE admitted to Shahid Madani hospital, Tabriz, Iran. Computed tomography pulmonary angiography (CTPA) was used to diagnose APE. A checklist was prepared for all patients, demographic, clinical characteristics, and Major Adverse Cardiopulmonary events (MACPE), including in-hospital mortality, need for thrombolysis, mechanical ventilation, and surgical embolectomy, were recorded. Patients were divided into two groups: patients who manifested fQRS on their ECG and patients who did not; Then, demographic, clinical characteristics, and MACPE were compared in the two groups, as mentioned earlier. Furthermore, all statistical analyses were carried out using SPSS software.</p><p><strong>Results: </strong>48 patients (17.14%) had fQRS(+) on their ECG, and 232 patients (82.86%) did not have it on their ECG. In data analysis, 22 patients (8.7%) had in-hospital mortality, 35 patients (13.9%) needed thrombolysis, nine patients (3.9%) required mechanical ventilation, and 13 patients (5.1%) needed surgical embolectomy. fQRS was not significantly associated with in-hospital mortality (P = 0.225), need for thrombolysis (P = 0.684), mechanical ventilation (P = 1.000), and surgical embolectomy (P = 1.000). Demographic and clinical characteristics were also similar in both groups.</p><p><strong>Conclusions: </strong>This study does not support the idea that fQRS on ECG is a valuable predictor of in-hospital mortality, the need for thrombolysis, mechanical ventilation, and surgical embolectomy.</p>","PeriodicalId":7427,"journal":{"name":"American journal of cardiovascular disease","volume":"13 1","pages":"21-28"},"PeriodicalIF":1.3,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017924/pdf/ajcd0013-0021.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9145052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信